Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.

Identifieur interne : 000102 ( Main/Exploration ); précédent : 000101; suivant : 000103

Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.

Auteurs : Vic Eton [Canada] ; Annette Schroeter [Canada] ; Len Kelly [Canada] ; Michael Kirlew [Canada] ; Raymond S W. Tsang [Canada] ; Marina Ulanova [Canada]

Source :

RBID : pubmed:28951105

Descripteurs français

English descriptors

Abstract

INTRODUCTION

North American indigenous populations experience a high burden of invasive bacterial infections. Because Streptococcus pneumoniae and Haemophilus influenzae have multiple antigenic variants, the existing vaccines cannot prevent all cases. This study addresses the current epidemiology of invasive H. influenzae and pneumococcal disease (IPD) in a region of Northwestern Ontario, Canada with a relatively high (82%) indigenous population.

METHODS

Data were retrieved from a retrospective chart review at a hospital servicing a population of 29000 (82% indigenous), during January 2010-July 2015.

RESULTS

Ten cases of invasive H. influenzae disease and 37 cases of IPD were identified. The incidence of both in the study population (6.3 and 23.1/100000/year, respectively) exceeded national rates (1.6 and 9.0/100000/year). H. influenzae serotype a (Hia) was the most common (50%), followed by non-typeable H. influenzae (20%). In adults, 77% of IPD cases were caused by serotypes included in the 23-valent pneumococcal polysaccharide vaccine. All paediatric IPD cases were caused by serotypes not included in the 13-valent pneumococcal conjugate vaccine. The case-fatality rate was 10% for invasive H. influenzae and 2.7% for IPD. Most cases exhibited substantial co-morbidity.

CONCLUSIONS

In Northwestern Ontario, the incidence of invasive Hia disease exceeds that of H. influenzae type b (Hib) in the pre-Hib vaccine era. This provides strong support for the development of a new Hia vaccine. Improved pneumococcal vaccination of high-risk adults in the region is warranted.


DOI: 10.1016/j.ijid.2017.09.016
PubMed: 28951105


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.</title>
<author>
<name sortKey="Eton, Vic" sort="Eton, Vic" uniqKey="Eton V" first="Vic" last="Eton">Vic Eton</name>
<affiliation wicri:level="1">
<nlm:affiliation>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada. Electronic address: etonvict@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1</wicri:regionArea>
<wicri:noRegion>Ontario P7B 5E1</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schroeter, Annette" sort="Schroeter, Annette" uniqKey="Schroeter A" first="Annette" last="Schroeter">Annette Schroeter</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kelly, Len" sort="Kelly, Len" uniqKey="Kelly L" first="Len" last="Kelly">Len Kelly</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kirlew, Michael" sort="Kirlew, Michael" uniqKey="Kirlew M" first="Michael" last="Kirlew">Michael Kirlew</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada; Northern Ontario School of Medicine, Sioux Lookout, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada; Northern Ontario School of Medicine, Sioux Lookout, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tsang, Raymond S W" sort="Tsang, Raymond S W" uniqKey="Tsang R" first="Raymond S W" last="Tsang">Raymond S W. Tsang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Winnipeg, Manitoba</wicri:regionArea>
<wicri:noRegion>Manitoba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ulanova, Marina" sort="Ulanova, Marina" uniqKey="Ulanova M" first="Marina" last="Ulanova">Marina Ulanova</name>
<affiliation wicri:level="1">
<nlm:affiliation>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada; Lakehead University, Thunder Bay, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada; Lakehead University, Thunder Bay, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28951105</idno>
<idno type="pmid">28951105</idno>
<idno type="doi">10.1016/j.ijid.2017.09.016</idno>
<idno type="wicri:Area/Main/Corpus">000077</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000077</idno>
<idno type="wicri:Area/Main/Curation">000077</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000077</idno>
<idno type="wicri:Area/Main/Exploration">000077</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.</title>
<author>
<name sortKey="Eton, Vic" sort="Eton, Vic" uniqKey="Eton V" first="Vic" last="Eton">Vic Eton</name>
<affiliation wicri:level="1">
<nlm:affiliation>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada. Electronic address: etonvict@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1</wicri:regionArea>
<wicri:noRegion>Ontario P7B 5E1</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schroeter, Annette" sort="Schroeter, Annette" uniqKey="Schroeter A" first="Annette" last="Schroeter">Annette Schroeter</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kelly, Len" sort="Kelly, Len" uniqKey="Kelly L" first="Len" last="Kelly">Len Kelly</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kirlew, Michael" sort="Kirlew, Michael" uniqKey="Kirlew M" first="Michael" last="Kirlew">Michael Kirlew</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada; Northern Ontario School of Medicine, Sioux Lookout, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada; Northern Ontario School of Medicine, Sioux Lookout, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tsang, Raymond S W" sort="Tsang, Raymond S W" uniqKey="Tsang R" first="Raymond S W" last="Tsang">Raymond S W. Tsang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Winnipeg, Manitoba</wicri:regionArea>
<wicri:noRegion>Manitoba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ulanova, Marina" sort="Ulanova, Marina" uniqKey="Ulanova M" first="Marina" last="Ulanova">Marina Ulanova</name>
<affiliation wicri:level="1">
<nlm:affiliation>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada; Lakehead University, Thunder Bay, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada; Lakehead University, Thunder Bay, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</title>
<idno type="eISSN">1878-3511</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antigenic Variation</term>
<term>Bacterial Capsules</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Haemophilus Infections (epidemiology)</term>
<term>Haemophilus Infections (prevention & control)</term>
<term>Haemophilus Vaccines (administration & dosage)</term>
<term>Haemophilus influenzae</term>
<term>Humans</term>
<term>Incidence</term>
<term>Infant</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Morbidity</term>
<term>Ontario (epidemiology)</term>
<term>Pneumococcal Infections (epidemiology)</term>
<term>Pneumococcal Infections (prevention & control)</term>
<term>Pneumococcal Vaccines (administration & dosage)</term>
<term>Retrospective Studies</term>
<term>Streptococcus pneumoniae</term>
<term>Vaccination</term>
<term>Vaccines, Conjugate (administration & dosage)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Capsules bactériennes</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Haemophilus influenzae</term>
<term>Humains</term>
<term>Incidence</term>
<term>Infections à Haemophilus ()</term>
<term>Infections à Haemophilus (épidémiologie)</term>
<term>Infections à pneumocoques ()</term>
<term>Infections à pneumocoques (épidémiologie)</term>
<term>Jeune adulte</term>
<term>Morbidité</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Ontario (épidémiologie)</term>
<term>Streptococcus pneumoniae</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccination</term>
<term>Vaccins anti-Haemophilus (administration et posologie)</term>
<term>Vaccins antipneumococciques (administration et posologie)</term>
<term>Vaccins conjugués (administration et posologie)</term>
<term>Variation des antigènes</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Haemophilus Vaccines</term>
<term>Pneumococcal Vaccines</term>
<term>Vaccines, Conjugate</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins anti-Haemophilus</term>
<term>Vaccins antipneumococciques</term>
<term>Vaccins conjugués</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Haemophilus Infections</term>
<term>Influenza, Human</term>
<term>Ontario</term>
<term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Haemophilus Infections</term>
<term>Influenza, Human</term>
<term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections à Haemophilus</term>
<term>Infections à pneumocoques</term>
<term>Ontario</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antigenic Variation</term>
<term>Bacterial Capsules</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Haemophilus influenzae</term>
<term>Humans</term>
<term>Incidence</term>
<term>Infant</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Morbidity</term>
<term>Retrospective Studies</term>
<term>Streptococcus pneumoniae</term>
<term>Vaccination</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Capsules bactériennes</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Haemophilus influenzae</term>
<term>Humains</term>
<term>Incidence</term>
<term>Infections à Haemophilus</term>
<term>Infections à pneumocoques</term>
<term>Jeune adulte</term>
<term>Morbidité</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Streptococcus pneumoniae</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccination</term>
<term>Variation des antigènes</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>INTRODUCTION</b>
</p>
<p>North American indigenous populations experience a high burden of invasive bacterial infections. Because Streptococcus pneumoniae and Haemophilus influenzae have multiple antigenic variants, the existing vaccines cannot prevent all cases. This study addresses the current epidemiology of invasive H. influenzae and pneumococcal disease (IPD) in a region of Northwestern Ontario, Canada with a relatively high (82%) indigenous population.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Data were retrieved from a retrospective chart review at a hospital servicing a population of 29000 (82% indigenous), during January 2010-July 2015.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Ten cases of invasive H. influenzae disease and 37 cases of IPD were identified. The incidence of both in the study population (6.3 and 23.1/100000/year, respectively) exceeded national rates (1.6 and 9.0/100000/year). H. influenzae serotype a (Hia) was the most common (50%), followed by non-typeable H. influenzae (20%). In adults, 77% of IPD cases were caused by serotypes included in the 23-valent pneumococcal polysaccharide vaccine. All paediatric IPD cases were caused by serotypes not included in the 13-valent pneumococcal conjugate vaccine. The case-fatality rate was 10% for invasive H. influenzae and 2.7% for IPD. Most cases exhibited substantial co-morbidity.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>In Northwestern Ontario, the incidence of invasive Hia disease exceeds that of H. influenzae type b (Hib) in the pre-Hib vaccine era. This provides strong support for the development of a new Hia vaccine. Improved pneumococcal vaccination of high-risk adults in the region is warranted.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">28951105</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>04</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-3511</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>65</Volume>
<PubDate>
<Year>2017</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
<ISOAbbreviation>Int. J. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.</ArticleTitle>
<Pagination>
<MedlinePgn>27-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1201-9712(17)30240-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2017.09.016</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">North American indigenous populations experience a high burden of invasive bacterial infections. Because Streptococcus pneumoniae and Haemophilus influenzae have multiple antigenic variants, the existing vaccines cannot prevent all cases. This study addresses the current epidemiology of invasive H. influenzae and pneumococcal disease (IPD) in a region of Northwestern Ontario, Canada with a relatively high (82%) indigenous population.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Data were retrieved from a retrospective chart review at a hospital servicing a population of 29000 (82% indigenous), during January 2010-July 2015.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten cases of invasive H. influenzae disease and 37 cases of IPD were identified. The incidence of both in the study population (6.3 and 23.1/100000/year, respectively) exceeded national rates (1.6 and 9.0/100000/year). H. influenzae serotype a (Hia) was the most common (50%), followed by non-typeable H. influenzae (20%). In adults, 77% of IPD cases were caused by serotypes included in the 23-valent pneumococcal polysaccharide vaccine. All paediatric IPD cases were caused by serotypes not included in the 13-valent pneumococcal conjugate vaccine. The case-fatality rate was 10% for invasive H. influenzae and 2.7% for IPD. Most cases exhibited substantial co-morbidity.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In Northwestern Ontario, the incidence of invasive Hia disease exceeds that of H. influenzae type b (Hib) in the pre-Hib vaccine era. This provides strong support for the development of a new Hia vaccine. Improved pneumococcal vaccination of high-risk adults in the region is warranted.</AbstractText>
<CopyrightInformation>Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Eton</LastName>
<ForeName>Vic</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada. Electronic address: etonvict@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schroeter</LastName>
<ForeName>Annette</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kelly</LastName>
<ForeName>Len</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kirlew</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Sioux Lookout Meno Ya Win Health Centre, Sioux Lookout, Ontario, Canada; Northern Ontario School of Medicine, Sioux Lookout, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsang</LastName>
<ForeName>Raymond S W</ForeName>
<Initials>RSW</Initials>
<AffiliationInfo>
<Affiliation>Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Winnipeg, Manitoba, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ulanova</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Northern Ontario School of Medicine, 955 Oliver Road, Thunder Bay, Ontario P7B 5E1, Canada; Lakehead University, Thunder Bay, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>09</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>Int J Infect Dis</MedlineTA>
<NlmUniqueID>9610933</NlmUniqueID>
<ISSNLinking>1201-9712</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C414006">23-valent pneumococcal capsular polysaccharide vaccine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018073">Haemophilus Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C044237">Haemophilus influenzae type b polysaccharide vaccine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018074">Vaccines, Conjugate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000940" MajorTopicYN="N">Antigenic Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016667" MajorTopicYN="N">Bacterial Capsules</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006192" MajorTopicYN="N">Haemophilus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018073" MajorTopicYN="N">Haemophilus Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006193" MajorTopicYN="N">Haemophilus influenzae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009864" MajorTopicYN="N">Ontario</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018074" MajorTopicYN="N">Vaccines, Conjugate</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Canada</Keyword>
<Keyword MajorTopicYN="N">Haemophilus influenzae</Keyword>
<Keyword MajorTopicYN="N">Indigenous</Keyword>
<Keyword MajorTopicYN="N">Invasive disease</Keyword>
<Keyword MajorTopicYN="N">Pneumococcal</Keyword>
<Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>05</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>09</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>09</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28951105</ArticleId>
<ArticleId IdType="pii">S1201-9712(17)30240-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijid.2017.09.016</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Eton, Vic" sort="Eton, Vic" uniqKey="Eton V" first="Vic" last="Eton">Vic Eton</name>
</noRegion>
<name sortKey="Kelly, Len" sort="Kelly, Len" uniqKey="Kelly L" first="Len" last="Kelly">Len Kelly</name>
<name sortKey="Kirlew, Michael" sort="Kirlew, Michael" uniqKey="Kirlew M" first="Michael" last="Kirlew">Michael Kirlew</name>
<name sortKey="Schroeter, Annette" sort="Schroeter, Annette" uniqKey="Schroeter A" first="Annette" last="Schroeter">Annette Schroeter</name>
<name sortKey="Tsang, Raymond S W" sort="Tsang, Raymond S W" uniqKey="Tsang R" first="Raymond S W" last="Tsang">Raymond S W. Tsang</name>
<name sortKey="Ulanova, Marina" sort="Ulanova, Marina" uniqKey="Ulanova M" first="Marina" last="Ulanova">Marina Ulanova</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000102 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000102 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28951105
   |texte=   Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28951105" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020